WO2009045492A1 - Optical device components - Google Patents

Optical device components Download PDF

Info

Publication number
WO2009045492A1
WO2009045492A1 PCT/US2008/011438 US2008011438W WO2009045492A1 WO 2009045492 A1 WO2009045492 A1 WO 2009045492A1 US 2008011438 W US2008011438 W US 2008011438W WO 2009045492 A1 WO2009045492 A1 WO 2009045492A1
Authority
WO
WIPO (PCT)
Prior art keywords
light
light beams
target area
lens
collection system
Prior art date
Application number
PCT/US2008/011438
Other languages
French (fr)
Inventor
Zhi Xu
Original Assignee
The Curators Of The University Of Missouri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Curators Of The University Of Missouri filed Critical The Curators Of The University Of Missouri
Priority to RU2010117396/28A priority Critical patent/RU2478197C2/en
Priority to AU2008307505A priority patent/AU2008307505B2/en
Priority to BRPI0818177-2A priority patent/BRPI0818177B1/en
Priority to JP2010527994A priority patent/JP2010540964A/en
Priority to CA2700996A priority patent/CA2700996C/en
Priority to CN2008801167527A priority patent/CN101903757B/en
Priority to EP08836010.2A priority patent/EP2198268B1/en
Publication of WO2009045492A1 publication Critical patent/WO2009045492A1/en
Priority to HK11105392.0A priority patent/HK1151351A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/4738Diffuse reflection, e.g. also for testing fluids, fibrous materials
    • G01N21/474Details of optical heads therefor, e.g. using optical fibres

Definitions

  • a fundamental property of a sample is its tendency or lack of tendency to absorb or scatter light at certain wavelengths. Characterization of the tendency of a sample to absorb, scatter or transmit is the basis for many optical measurements and instrumentation (e.g., spectrophotometry). The accuracy and repeatability of measurements taken with optical devices relates to many factors, including the strength of signal reaching one or more detectors.
  • Optical devices may be used to measure the presence and quantities of components in human or animal blood or interstitial fluid.
  • a non-invasive optical apparatus may use some form of spectroscopy to acquire the signal or spectrum from a target area of a body of the user.
  • Diabetes is a chronic disease that, when not controlled, over time leads to serious damage to many of the body's systems, including the nerves, blood vessels, eyes, kidneys and heart.
  • NIDDK National Institute of Diabetes and Digestive and Kidney Diseases
  • WHO World Health Organization
  • a vital element of diabetes management is the self-monitoring of blood glucose (SMBG) concentration by diabetics in the home environment. By testing blood glucose levels often, diabetics can better manage medication, diet and exercise to maintain control and prevent the long-term negative health outcomes.
  • SMBG blood glucose
  • a non-invasive monitor will make testing multiple times each day pain-free and more palatable for children with diabetes. According to a study published in 2005 (J, Wagner, C. Malchoff, and G. Abbott, Diabetes Technology & Therapeutics, 7(4) 2005, 612 - 619), people with diabetes would perform SMBG more frequently and have improved quality of life with a non-invasive blood glucose monitoring device. [0007] There exist a number of non-invasive approaches for blood glucose determination.
  • One technique of non-invasive blood chemicals detection involves collecting and analyzing light spectra data.
  • Extracting information about blood characteristics such as glucose concentration from spectral or other data obtained from spectroscopy is a complex problem due to the presence of components (e.g., skin, fat, muscle, bone, interstitial fluid) other than blood in the area that is being sensed. Such other components can influence these signals in such a way as to alter the reading.
  • the resulting signal may be much larger in magnitude than the portion of the signal that
  • SLW Docket No. 2743.003WOI corresponds to blood, and therefore limits the ability to accurately extract blood characteristics information.
  • Embodiments of the invention relate to. an apparatus including a light source to generate a plurality of light beams with each of the plurality of light beams having a different wavelength range.
  • the apparatus also includes a light funnel to direct the plurality of light beams to the target area, an aperture to direct the plurality of light beams emitting from the target area to a lens, the lens configured to collect the light beams emitting from the target area.
  • the apparatus includes a detector including a plurality of light-sensing devices each configured to detect a light beam and configured to generate an output signal indicative of an intensity of light detected and a processor for determining the blood characteristic as a function of each generated output signal.
  • Embodiments relate to a light collection system, including a lens positioned adjacent a target area, an aperture positioned between the lens and target area and configured to direct a plurality of light beams emitting from the target area; and one or more filters,
  • FIGS. IA-B illustrate plots of a pulse wave corresponding to light absorption of arterial blood, according to some embodiments.
  • FIG. 2 illustrates an optical configuration, according to some embodiments.
  • FIG. 3 illustrates an existing optical configuration for performing optical measurements of a biological sample, according to some embodiments.
  • FIGS. 4A-B illustrate optical configurations for performing optical measurements of a biological sample, according to some embodiments.
  • FIG. 5 illustrates a cross sectional view of a light funnel, according to some embodiments.
  • FIG. 6 illustrates components of the light source, according to some embodiments.
  • FIG. 7 illustrates a cross-sectional view of a light funnel with an infrared emitting diode (IRED) array matrix disposed therein, according to some embodiments.
  • IRED infrared emitting diode
  • Embodiments of the present invention relate to optical components, such as light funnels for illumination and measurement of optical properties of a sample.
  • SLW Docket No. 2743.003WOI 4 body regions are exemplified, the embodiments relate to all types of optical instrumentation, including optical detectors, microscopes, spectrometers, etc.
  • Optical spectroscopy can be used to determine the amount of light absorbed by a biological sample such as human finger. By measuring the amount of light absorbed by the finger, it is possible to determine glucose, cholesterol, and hemoglobin levels of a person non-invasively. Fingertip measurements are usually preferred because of the large concentration of capillaries in the fingertip and because of the conversion of arterial blood into venous blood that occurs in the fingertip.
  • FIG. IA depicts a plot 102 of a pulse wave that corresponds to the light absorption of arterial blood in the capillary due to the heartbeat of the user.
  • the magnitude of the cyclic pattern is small in comparison to the total photocurrent generated by the detector, considerable information can be extracted from the cyclic pattern of the plot 102.
  • the plot will have a maximum or peak 104 reading and minimum or valley 106 reading.
  • the peak 104 reading of the plot corresponds to when there is a minimum amount of blood in the capillaries
  • the valley 106 reading corresponds to when there is a maximum amount of blood in the capillaries.
  • the transmittances corresponding to the peak and valley photo currents can be defined as:
  • the baseline noise of the device being used to measure the light absorption by the finger should not be larger than 3.0 ⁇ 10 "5 in absorbance (peak to peak), within a 10 Hz bandwidth.
  • a 3.0 x 10 "5 absorbance (peak to peak) baseline noise level within a 10 Hz bandwidth is difficult to obtain with the low light power levels that are used by some battery powered hand held non-invasive blood
  • SLW Docket No. 2743.003WOI 6 chemicals measurement devices One solution involves increasing light illumination power. However, due to size limitations of some devices, it may not be possible or it may be inefficient to increase illumination power to achieve a desired baseline noise level (e.g., battery drain). Thus, there is a need for a system and method to increase the amount light power that can be detected by such devices without significantly increasing device size and battery power consumption.
  • FIG. 2 is a simplified block diagram that illustrates components of a current optical measurement system 200 that uses the "pulsatile" concept for determining an amount of light absorbed and scattered solely by the blood in a human finger.
  • a power source 201 such as a battery, provides power to a light source 202 that generates a plurality of light beams 204, 206, 208, 210 that are directed toward the top of the finger of a user.
  • each of the light beams 204, 206, 208, 210 have a different wavelength or a different wavelength range, typically within 800 ran to 1600 nm.
  • the first light beam 204 may have a wavelength range between 850-900 nm
  • the second light beam 206 may have a wavelength range between 875-940 nm
  • the third light beam 208 may have a wavelength between 920-980 nm
  • the fourth light beam 210 may have a wavelength between 950-1050 nm.
  • the optical measurement system 200 is described herein as generating four (4) light beams, it is contemplated that the light source 202 can be altered to generate fewer light beams or additional light beams in other embodiments.
  • a first aperture 212 ensures that the light beams 204, 206, 208, 210 strike a target area of the finger.
  • a second aperture 214 ensures that the portion of the light beams that are transmitted through the finger strike a lens 216.
  • Light beams 204, 206, 208, 210 are attenuated by the finger and components of the optical measurement system 200, and, thus, attenuated light beams 218, 220, 222, 224 are emitted from the finger.
  • the attenuated light beams 218, 220, 222, 224 strike the lens 216, and the lens 216 collects the attenuated light beams 218, 220, 222, 224 so that they impinge more efficiently on a detector block 226.
  • the detector block 226 is positioned directly under the lens 216 and comprises a plurality of light-sensing devices (LSD) 228, 230, 232, 234 such
  • each of the light-sensing devices 228, 230, 232, 234 detects a specific wavelength of light as defined by corresponding interference filters (IF) 236, 238, 240, 242, respectively.
  • the interference filter transmits one or more spectral bands or lines of light, and blocks others.
  • Each of the light-sensing devices 228, 230, 232, 234 generates a corresponding current signal that is proportional to the power of the light received by the particular light sensing device.
  • the current signal generated by the photodiode can be converted to another form of signal, such as an analog voltage signal or a digital signal.
  • a processor 243 is coupled to the detector block 226 and is configured to calculate the change of photo current signals 244, 246, 248, 250. [0041] According to one aspect, the processor 243 executes an algorithm such as shown in the equation (5) to calculate the change in the light absorption ( ⁇ A) solely caused by the blood in the finger. Thereafter, this quantitative calculation of light absorption of the blood can be used to determine a characteristic of the blood. For example, by comparing the calculated light absorption value to predetermined values corresponding to different glucose levels stored in a memory (not shown), a glucose level of the user can be determined.
  • An Infrared Emitting Diode (“IRED") block 302 includes a plurality of IREDs that generate near infrared (“NIR”) radiation or light beams from 850 nm to 1100 nm.
  • the generated NIR light beams enter an entrance aperture 304 and pass through the finger.
  • the NIR light beams transmitted through the finger pass through an exit aperture 306 onto a lens 308.
  • the lens 308 collimates light beams and projects them onto filter array 310 and then detector array 312.
  • the apparatus also includes a wall housing 314 to prevent stray light from reaching the light detectors.
  • the light beams passing through the exit aperture 306 are completely mixed in wavelength. More specifically, the entire light power distribution from 850 nm to 1100 nm is transmitted to every detector in the detector array 312.
  • the total usable power is approximately five (5) mW (e.g., 4 x 2.5 mW x .50) for the entire wavelength range covered by the four IREDs, typically 850 nm to 1 100 nm.
  • the light that enters the finger will be attenuated by skin, fat, muscle, blood, and bone.
  • absorption and scattering of light by the human finger can reduce the power of transmitted light within the NIR region of 850 nm to 1100 nm by a factor of approximately 200.
  • the total IR power transmitted through the finger is approximately only 25 microwatts ( ⁇ W) (e.g., 5mW/200) in the entire wavelength region covered by the four IREDs, typically 850 nm to 1 100 nm.
  • SLW Docket No. 2743.003WOI 9 aperture 306 cannot be treated as a point source.
  • the total light power collected using optical layout shown in Fig. 3 is only about 10%, or a power reduction by a factor of 10 to 2.5 ⁇ W within the entire wavelength region covered by the four IREDs, typically 850 nm to 1100 nm. Note that this is the optical power sent to all detectors in FIG. 3.
  • optical systems such as shown in FIG. 3, may require as many as twenty (20) to thirty (30) diode detectors to obtain accurate information regarding chemical components in blood. Therefore, the light power goes to each detector will be about 125 nW or less.
  • the interference filter placed on top of each detector typically has a full width at half maximum (FWHM) bandwidth of 10 nm, which reduces the light power by a factor of 25 to 5 nW, assuming a uniform power distribution across the entire wavelength region from 850 nm to 1100 nm. Furthermore, the peak transmittance of each interference filter is about 50% or less. Accordingly, the light power received by each detector is reduced to about 2.5 nW or less.
  • FWHM full width at half maximum
  • the photoelectric conversion efficiency for Silicon Diode detectors ranges from 0.1 amps/watts (AAV) at 1100 nm to about 0.5 AAV at 900 nm.
  • AAV amps/watts
  • the photocurrent produced by each detector is between 0.25 nano-amps or less (nA) to 1.25 nA or less for each detector.
  • the corresponding high end shot noise, within 10 Hz bandwidth, is about 2.0 x 10 "4 Absorbance (p- p) or larger, which is over a factor of 6 of what is required for accurate determination of the value of ⁇ A, as defined by equation (5), with an S/N ratio of 100.
  • FIG. 4 A illustrates an optical configuration for performing optical detection of a biological sample according to one aspect of the present optical measurement system 400.
  • a light source 402 generates a plurality of
  • each of the light beams 404, 406, 408, 410 have a different wavelength or a different wavelength range.
  • the first light beam 404 may have a wavelength range between 850 - 920 nm
  • the second light beam 406 may have a wavelength range between 900 - 980 nm
  • the third light beam 408 may have a wavelength between 970 - 1050 nm
  • the fourth light beam 410 may have a wavelength between 1030-1100 nm.
  • the total wavelength range may include from about 800 nm to about 1600nm, for example.
  • the optical measurement system 400 is described herein as generating four (4) light beams, it is contemplated that the light source can be altered to generate fewer light beams or additional light beams in other embodiments.
  • the light beams 404, 406, 408, 410 from the light source 402 enter a light illumination funnel 412 through an entrance opening 414 and exit the light illumination funnel 412 through an exit opening 416.
  • the diameter of the exit opening 416 of the light illumination funnel 412 is smaller than or equal to the diameter of the entrance opening 414.
  • the diameter of the entrance opening 414 is approximately 0.625 (5/8) inches and the diameter of the exit opening 416 is approximately 0.25 (1/4) inches.
  • the light illumination funnel 412 focuses the light beams 404, 406, 408, 410 in the same general direction toward the top of the finger of a user.
  • the light illumination funnel may significantly increase the total light power received by the target area in comparison to the configuration of FIG. 3, and therefore substantially increase the Signal-to-Noise Ratio.
  • FIG. 5 depicts a cross sectional view of the light illumination component or funnel 412.
  • the light illumination funnel 412 has a substantially cylindrical outer wall 502 with diameter Dl, and a central cavity defined by an inner wall 506 that is of a frusto-conical shape and two light entrance/exit openings 508 and 504.
  • the opening 508 (second opening) has a smaller diameter, D3, and opening 504 (first opening) has a larger diameter, D2.
  • the separation distance between the two light openings is L
  • the Half Angle of the frusto-conical shape of the inner surface is ⁇ .
  • the value of Half Angle ⁇ ranges from 10 to 15 degrees.
  • the Half Angles may be less than about 25 degrees, for example.
  • the light illumination funnel 412 may be formed from plastic, metal or other suitable material or compound/layers of material, with any desired refractive index(es). According to one aspect, the light illumination funnel 412 is formed from metal and the surface of inner wall 506 is made highly reflective. When configured properly, the light intensity at the exit 508 may be increased by a factor of 50 to 100 over the light intensity at the entrance 504. [0054] FIG. 6 depicts components of the light source 402 according to one aspect of the optical measurement system 400.
  • a circuit board may be positioned near or in contact with the first opening of the funnel and may include light sources mounted on or in contact with the board.
  • a plurality of IREDs 602, 604, 606, and 608 are mounted to a printed circuit board (PCB) 610.
  • the PCB 610 receives electric power through a power line 612 that is connected to a power source (e.g., power source 201) such as a battery.
  • a power source e.g., power source 201
  • each of the IREDs 602, 604, 606, and 608 receives power and generates a plurality of light beams (e.g., light beams 404, 406, 408, 410).
  • IREDs with similar operational current can be connected in series to increase battery life.
  • the light source may be mounted within the funnel or above the funnel, such as by being surrounded by a housing, for example.
  • the light illumination funnel 412 may be mounted to the PCB 610 via screws, posts or other connecting means.
  • the frusto-conical shape of the inner surface of the light illumination funnel 412 serves to concentrate and focus the light beams 404, 406, 408, 410 from the IREDs 602, 604, 606, 608 into a generally conical beam toward the finger.
  • FIG. 7 depicts cross-section view of another embodiment of the light illumination funnel 412 with a three-dimensional (3-D) IRED array matrix 702 disposed therein.
  • Multiple light sources, such as IREDs may be positioned in three-dimensional layers and arranged to optimize light intensity.
  • the light sources may be positioned in horizontal and vertical layers, for example. According to this embodiment, there are a total of twenty six (26) IREDs included in the 3-D array matrix.
  • the IREDs are arranged in four (4) layers.
  • a second layer, as indicated by 706, includes five (5) IREDs (two IREDs not shown), a third layer, as indicated by 708, includes seven (7) IREDs (four IREDs not shown), and a fourth layer, as indicated by 710, includes ten (10) IREDs (six IREDs not shown).
  • Power line 712 provides power for all IREDs. According to other embodiments, other IRED patterns may also be utilized. Any number of light sources or layers may be utilized to optimize the light intensity. [0057] Because IREDs are optically transparent to infrared lights, the light loss due to blocking effect within the funnel cavity should be low and the structure shown in FIG.
  • the total light power transmitted through the 0.25-inch diameter of the exit opening 416 of the light illumination funnel 412 should be approximately 55 mW (e.g., 26 x 2.5 mW x 0.85). Therefore, the total light power transmitted through the 0.25 inch opening above the finger in present optical measurement system 400 is approximately eleven (11) times of the corresponding power reached at the aperture 306 (e.g., 5mW) of the configuration described in reference to FIG. 3. Moreover, the increased light power received at the finger will increase the amount of light power that can be transmitted through the finger and, thus, increases the light power that can be detected at the detector block 428.
  • light beams 404, 406, 408, 410 are attenuated by the finger and components of the optical measurement system 400.
  • the attenuated light beams then pass an exit aperture 418, collected by an aspheric lens 430.
  • the beams 432 exiting the lens 430 may then pass through filters 426 to detectors 428.
  • the major advantage of using an aspheric lens 430 for light collection is its much larger solid angle for light collection.
  • the total light power received by each detector may be increased by a factor 3 to 4 when an aspheric lens 430 is used for collecting light emitted from the target area in comparison to the light collection configuration shown in FIG. 3.
  • the combination of utilizing a light illumination funnel 412 and an aspheric lens 430 as light collector may increase the light power received by each detector by about 20 to about 40 times in comparison to the optical configuration shown in FIG. 3
  • the detector block 428 is positioned beneath the aspheric lens
  • each of the light-sensing devices detects a specific wavelength of light as defined by a corresponding interference filter 426 placed on top of the detector.
  • a processor e.g., processor 243 can be coupled to the detector block 428 and configured to calculate a change of current signals generated by the light sensing devices. For example, as described above in reference to FIG. 2, the processor 243 executes an algorithm such as shown in equation (5) to calculate the change in the light absorption ( ⁇ A) solely caused by the blood in the finger. Thereafter, this quantitative calculation of light absorption of the blood can be used to determine a characteristic of the blood.
  • FIG. 4B illustrates another optical configuration for performing optical detection of a biological sample according to one aspect of the present optical measurement system 400.
  • a light source 402 generates a plurality of light beams 404, 406, 408, 410.
  • the light source 402 may be incandescent light sources or infrared emitting diodes, for example.
  • each of the light beams 404, 406, 408, 410 have a different wavelength or a different wavelength range.
  • the first light beam 404 may have a wavelength range between 850 - 920 nm
  • the second light beam 406 may have a wavelength range between 900 - 980 nm
  • the third light beam 408 may have a wavelength between 970 - 1050 nm
  • the fourth light beam 410 may have a wavelength between 1030-1100 nm.
  • the total wavelength range may include from about 800 nm to about 1200nm, for example.
  • the optical measurement system 400 is described herein as generating four (4) light beams, it is contemplated that the light source can be altered to generate fewer light beams or additional light beams in other embodiments.
  • the light beams 404, 406, 408, 410 from the light source 402 enter a light illumination funnel 412 through an entrance opening 414 and exit the light illumination funnel 412 through an exit opening 416.
  • the diameter of the exit opening 416 of the light illumination funnel 412 is smaller than or equal to the diameter of the entrance opening 414.
  • the diameter of the entrance opening 414 is approximately 0.625
  • the light illumination funnel 412 focuses the light beams 404, 406, 408, 410 in the same general direction toward the top of the finger of a user.
  • the light illumination funnel may significantly increase the total light power received by the target area in comparison to the configuration of FIG. 3, and therefore substantially increase the Signal-to-Noise Ratio.
  • light beams 404, 406, 408, 410 are attenuated by the finger and components of the optical measurement system 400.
  • the attenuated light NIR beams then pass an exit aperture 418, collected by a condenser lens 420, and projected onto a transmission grating device 422.
  • the transmission diffraction grating 422 angularly resolves the various wavelength components of the mixed NIR light beams into a spectrum with wavelength increasing monotonically in the direction depicted by the arrow. In other words, because the diffraction angle of a particular light beam depends on the wavelength of the light beam, each of the light beams can be separated by wavelength.
  • the optical spectrum 424 comes out from the transmission diffraction grating 422 is then narrowed down by interference filter array 426 and detected by diode array 428.
  • the center wavelength of each interference filter in the filter array 426 is arranged to increase monotonically to coincide with corresponding wavelength component of the spectrum come from the transmission diffraction grating 422.
  • the approach utilizing transmission diffraction grating will send each detector only the wavelength components near the center wavelength of the corresponding filter.
  • the combination of utilizing a light illumination funnel 412, an aspheric lens 420 as light collector, and a transmission grating 422 as wavelength separation device may increase the light power received by the photodiodes by about 100 to about 200 times in comparison to the optical configuration shown in FIG. 3
  • Embodiments of the invention may also include methods of using the apparatus as describe above or a light collection system,
  • a light source may contact a target through an illumination funnel, sufficient to generate transmitted, transflected or reflected light.
  • the transmitted, transflected or reflected light may enter a light collection system and be directed to one or more detectors, for example.

Abstract

Embodiments of the invention relate to an apparatus including a light source to generate a plurality of light beams with each of the plurality of light beams having a different wavelength range. The apparatus also includes a light funnel to direct the plurality of light beams to the target area, an aperture to direct the plurality of light beams emitting from the target area to a lens, the lens configured to collect the light beams emitting from the target area. Further, the apparatus includes a detector including a plurality of light-sensing devices each configured to detect a light beam and configured to generate an output signal indicative of an intensity of light detected and a processor for determining the blood characteristic as a function of each generated output signal.

Description

OPTICAL DEVICE COMPONENTS
PRIORITY OF INVENTION
[0001] This non-provisional application claims the benefit of priority
U.S. Provisional Patent Application Serial No. 60/977,467, filed October 4, 2007, which is herein incorporated by reference in its entirety.
BACKGROUND
[0002] A fundamental property of a sample, whether it is a gas, liquid or solid, is its tendency or lack of tendency to absorb or scatter light at certain wavelengths. Characterization of the tendency of a sample to absorb, scatter or transmit is the basis for many optical measurements and instrumentation (e.g., spectrophotometry). The accuracy and repeatability of measurements taken with optical devices relates to many factors, including the strength of signal reaching one or more detectors. Optical devices may be used to measure the presence and quantities of components in human or animal blood or interstitial fluid. In one example, a non-invasive optical apparatus may use some form of spectroscopy to acquire the signal or spectrum from a target area of a body of the user.
[0003] Diabetes is a chronic disease that, when not controlled, over time leads to serious damage to many of the body's systems, including the nerves, blood vessels, eyes, kidneys and heart. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that 23.6 million people or 7.8 percent of the population in the United States have diabetes in 2007. Globally, the World Health Organization (WHO) estimates that more than 180 million people have diabetes, a number they expect to increase to 366 million by 2030, with 30.3 million in the United States. According to the WHO, an estimated 1.1 million people died from diabetes in 2005. They project that diabetes deaths will increase by more than 50% between 2006 and 2015 overall and by more than 80% in upper-middle income countries. [0004] The economic burden from diabetes for individuals and society as a whole is substantial. According to the American Diabetes Association, the total annual economic cost of diabetes was estimated to be $174 billion in the United
SLW Docket No. 2743.003WOI 1 States in 2007. This is an increase of $42 billion since 2002. This 32% increase means the dollar amount has risen over $8 billion more each year. [0005] A vital element of diabetes management is the self-monitoring of blood glucose (SMBG) concentration by diabetics in the home environment. By testing blood glucose levels often, diabetics can better manage medication, diet and exercise to maintain control and prevent the long-term negative health outcomes. In fact, the Diabetes Control and Complications Trial (DCCT), which followed 1,441 diabetics for several years, showed that those following an intensive-control program with multiple blood sugar tests each day as compared with the standard-treatment group had only 1A as many people develop diabetic eye disease, 1A as many develop kidney disease, 1A as many develop nerve disease, and far fewer people who already had early forms of these three complications got worse. [0006] However, current monitoring techniques discourage regular use due to the inconvenient and painful nature of drawing blood through the skin prior to analysis, which causes many diabetics to not be as diligent as they should be for good blood glucose control. As a result, non-invasive measurement of glucose concentration is a desirable and beneficial development for the management of diabetes. A non-invasive monitor will make testing multiple times each day pain-free and more palatable for children with diabetes. According to a study published in 2005 (J, Wagner, C. Malchoff, and G. Abbott, Diabetes Technology & Therapeutics, 7(4) 2005, 612 - 619), people with diabetes would perform SMBG more frequently and have improved quality of life with a non-invasive blood glucose monitoring device. [0007] There exist a number of non-invasive approaches for blood glucose determination. One technique of non-invasive blood chemicals detection involves collecting and analyzing light spectra data. Extracting information about blood characteristics such as glucose concentration from spectral or other data obtained from spectroscopy is a complex problem due to the presence of components (e.g., skin, fat, muscle, bone, interstitial fluid) other than blood in the area that is being sensed. Such other components can influence these signals in such a way as to alter the reading. In particular, the resulting signal may be much larger in magnitude than the portion of the signal that
SLW Docket No. 2743.003WOI corresponds to blood, and therefore limits the ability to accurately extract blood characteristics information.
SUMMARY [0008] Embodiments of the invention relate to. an apparatus including a light source to generate a plurality of light beams with each of the plurality of light beams having a different wavelength range. The apparatus also includes a light funnel to direct the plurality of light beams to the target area, an aperture to direct the plurality of light beams emitting from the target area to a lens, the lens configured to collect the light beams emitting from the target area. Further, the apparatus includes a detector including a plurality of light-sensing devices each configured to detect a light beam and configured to generate an output signal indicative of an intensity of light detected and a processor for determining the blood characteristic as a function of each generated output signal. [0009] Embodiments relate to a light collection system, including a lens positioned adjacent a target area, an aperture positioned between the lens and target area and configured to direct a plurality of light beams emitting from the target area; and one or more filters,
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] In the drawings, which are not necessarily drawn to scale, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.
[0011] FIGS. IA-B illustrate plots of a pulse wave corresponding to light absorption of arterial blood, according to some embodiments. [0012] FIG. 2 illustrates an optical configuration, according to some embodiments.
[0013] FIG. 3 illustrates an existing optical configuration for performing optical measurements of a biological sample, according to some embodiments. [0014] FIGS. 4A-B illustrate optical configurations for performing optical measurements of a biological sample, according to some embodiments.
SLW Docket No. 2743.003WO1 3 [0015] FIG. 5 illustrates a cross sectional view of a light funnel, according to some embodiments.
[0016] FIG. 6 illustrates components of the light source, according to some embodiments. [0017] FIG. 7 illustrates a cross-sectional view of a light funnel with an infrared emitting diode (IRED) array matrix disposed therein, according to some embodiments.
DETAILED DESCRIPTION [0018] The following detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments, which are also referred to herein as "examples," are described in enough detail to enable those skilled in the art to practice the invention. The embodiments may be combined, other embodiments may be utilized, or structural, and logical changes may be made without departing from the scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.
[0019] In this document, the terms "a" or "an" are used to include one or more than one and the term "or" is used to refer to a nonexclusive "or" unless otherwise indicated. In addition, it is to be understood that the phraseology or terminology employed herein, and not otherwise defined, is for the purpose of description only and not of limitation. Furthermore, all publications, patents, and patent documents referred to in this document are incorporated by reference herein in their entirety, as though individually incorporated by reference. In the event of inconsistent usages between this document and those documents so incorporated by reference, the usage in the incorporated reference should be considered supplementary to that of this document; for irreconcilable inconsistencies, the usage in this document controls. [0020] Embodiments of the present invention relate to optical components, such as light funnels for illumination and measurement of optical properties of a sample. Although spectroscopic sampling of human or animal
SLW Docket No. 2743.003WOI 4 body regions are exemplified, the embodiments relate to all types of optical instrumentation, including optical detectors, microscopes, spectrometers, etc. Optical spectroscopy can be used to determine the amount of light absorbed by a biological sample such as human finger. By measuring the amount of light absorbed by the finger, it is possible to determine glucose, cholesterol, and hemoglobin levels of a person non-invasively. Fingertip measurements are usually preferred because of the large concentration of capillaries in the fingertip and because of the conversion of arterial blood into venous blood that occurs in the fingertip. [0021] When light is transmitted through a biological sample, such as a human finger, the light is absorbed and scattered by various components of the finger including skin, muscle, bone, fat, interstitial fluid and blood. It has been observed, however, that light absorption by a human finger exhibits a small cyclic pattern that corresponds to a heartbeat. FIG. IA depicts a plot 102 of a pulse wave that corresponds to the light absorption of arterial blood in the capillary due to the heartbeat of the user. Although the magnitude of the cyclic pattern is small in comparison to the total photocurrent generated by the detector, considerable information can be extracted from the cyclic pattern of the plot 102. For example, assuming that the person's heart rate is sixty beats per minute, the time between the start of any pulse beat and the end of that pulse beat is one- second. During this one-second period, the plot will have a maximum or peak 104 reading and minimum or valley 106 reading. The peak 104 reading of the plot corresponds to when there is a minimum amount of blood in the capillaries, and the valley 106 reading corresponds to when there is a maximum amount of blood in the capillaries. By using optical information provided by the peak and valley of the cyclic plot, the optical absorption and scattering by major finger constituents that are not in the capillaries such as skin, fat, bones, muscle and interstitial fluids are excluded. These major constituents that are not in the capillaries are excluded because they are not likely to change during the one- second interval. In other words, the light that is absorbed by the blood can be detected based on the peaks and valleys of the plot 102. [0022] Assuming the peak of the cyclic photo current generated by the light-sensing device is Ip, the adjacent valley of the cyclic photo current is Iv, and the photo current generated by the light-sensing device without a human
SLW Docket No. 2743.003WO1 5 finger is I0, the transmittances corresponding to the peak and valley photo currents can be defined as:
Figure imgf000008_0001
[0024] and
[0025] TP = 1J- (2);
[0026] The corresponding peak a
[0027]
[0028] Λ = -log(?V ) (3);
[0029] and [0030] ^ = -log(7V) (4);
[0031] The difference between Ay and Ap reflects the light absorption and scattering by only the blood in the finger:
[0032] AA = Ay - Ap = log ^- (5);
[0033] The algorithms shown in equation (5) only require monitoring the change in photo current to determine a change in light power transmitted through the finger. As a result, there is no need to determine photo current generated by the light-sensing device without a human finger. [0034] Unfortunately, because the cyclic pattern is a very small signal, the amplitude of cyclic pattern (i.e., the difference between peak and valley) is typically 1% - 3% of the total light power transmitted through the finger. FIG. IA illustrates the cyclic pattern on a magnified scale. FIG. IB depicts a more accurate reflection of the cyclic pattern in terms of signal amplitude. To obtain a signal to noise (S/N) ratio of 100:1 in the determination of AA, the baseline noise of the device being used to measure the light absorption by the finger should not be larger than 3.0 χ 10"5 in absorbance (peak to peak), within a 10 Hz bandwidth. [0035] However, a 3.0 x 10"5 absorbance (peak to peak) baseline noise level within a 10 Hz bandwidth is difficult to obtain with the low light power levels that are used by some battery powered hand held non-invasive blood
SLW Docket No. 2743.003WOI 6 chemicals measurement devices. One solution involves increasing light illumination power. However, due to size limitations of some devices, it may not be possible or it may be inefficient to increase illumination power to achieve a desired baseline noise level (e.g., battery drain). Thus, there is a need for a system and method to increase the amount light power that can be detected by such devices without significantly increasing device size and battery power consumption.
[0036] FIG. 2 is a simplified block diagram that illustrates components of a current optical measurement system 200 that uses the "pulsatile" concept for determining an amount of light absorbed and scattered solely by the blood in a human finger. A power source 201 , such as a battery, provides power to a light source 202 that generates a plurality of light beams 204, 206, 208, 210 that are directed toward the top of the finger of a user. According to one aspect of the optical measurement system 200, each of the light beams 204, 206, 208, 210 have a different wavelength or a different wavelength range, typically within 800 ran to 1600 nm. For example, the first light beam 204 may have a wavelength range between 850-900 nm, the second light beam 206 may have a wavelength range between 875-940 nm, the third light beam 208 may have a wavelength between 920-980 nm, and the fourth light beam 210 may have a wavelength between 950-1050 nm. Although the optical measurement system 200 is described herein as generating four (4) light beams, it is contemplated that the light source 202 can be altered to generate fewer light beams or additional light beams in other embodiments. [0037] A first aperture 212 ensures that the light beams 204, 206, 208, 210 strike a target area of the finger. A second aperture 214 ensures that the portion of the light beams that are transmitted through the finger strike a lens 216. Light beams 204, 206, 208, 210 are attenuated by the finger and components of the optical measurement system 200, and, thus, attenuated light beams 218, 220, 222, 224 are emitted from the finger. The attenuated light beams 218, 220, 222, 224 strike the lens 216, and the lens 216 collects the attenuated light beams 218, 220, 222, 224 so that they impinge more efficiently on a detector block 226.
[0038] The detector block 226 is positioned directly under the lens 216 and comprises a plurality of light-sensing devices (LSD) 228, 230, 232, 234 such
SLW Docket No. 2743.003WO1 7 as an array of photodiodes. According to one aspect of the optical measurement system 200, each of the light-sensing devices 228, 230, 232, 234 detects a specific wavelength of light as defined by corresponding interference filters (IF) 236, 238, 240, 242, respectively. The interference filter transmits one or more spectral bands or lines of light, and blocks others.
[0039] Each of the light-sensing devices 228, 230, 232, 234 generates a corresponding current signal that is proportional to the power of the light received by the particular light sensing device. The current signal generated by the photodiode can be converted to another form of signal, such as an analog voltage signal or a digital signal.
[0040] A processor 243 is coupled to the detector block 226 and is configured to calculate the change of photo current signals 244, 246, 248, 250. [0041] According to one aspect, the processor 243 executes an algorithm such as shown in the equation (5) to calculate the change in the light absorption (ΔA) solely caused by the blood in the finger. Thereafter, this quantitative calculation of light absorption of the blood can be used to determine a characteristic of the blood. For example, by comparing the calculated light absorption value to predetermined values corresponding to different glucose levels stored in a memory (not shown), a glucose level of the user can be determined.
[0042] Referring now to FIG. 3, the configuration of a conventional apparatus for measuring the amount of light absorbed by a human finger. An Infrared Emitting Diode ("IRED") block 302 includes a plurality of IREDs that generate near infrared ("NIR") radiation or light beams from 850 nm to 1100 nm. The generated NIR light beams enter an entrance aperture 304 and pass through the finger. The NIR light beams transmitted through the finger pass through an exit aperture 306 onto a lens 308. The lens 308 collimates light beams and projects them onto filter array 310 and then detector array 312. The apparatus also includes a wall housing 314 to prevent stray light from reaching the light detectors.
[0043] In this optical configuration, the light beams passing through the exit aperture 306 are completely mixed in wavelength. More specifically, the entire light power distribution from 850 nm to 1100 nm is transmitted to every detector in the detector array 312.
SLW Docket No. 2743.003WO1 8 [0044] As described below, there are issues with the device configuration depicted in FIG. 3 that hamper the effectiveness of the device and that result in the potential high baseline noise.
Low Light Illumination Power
[0045] To accommodate small finger size of children, light should enter the finger through an entrance aperture 304 having a diameter of approximately 0.25 (1/4) inches or less, and that the light transmitted through the finger should be collected through an exit aperture 306 having a diameter of approximately 0.25 (1/4) inches or less. However, the number of IRED that can be placed into a 0.25-inch diameter area is limited. For example, only four 3 millimeter (mm) diameter IREDs can be effectively placed into the 0.25-inch diameter area of the entrance aperture 304. Because the average power from each IREDs is about 2.5 milliwatts (mW) with fifteen (15) to twenty (20) degrees half power emission angle, the total usable power that enters the finger from each IRED is approximately fifty percent (50%), or 1.25 mW. Thus, for four (4) IRED, the total usable power is approximately five (5) mW (e.g., 4 x 2.5 mW x .50) for the entire wavelength range covered by the four IREDs, typically 850 nm to 1 100 nm.
Absorption and Scattering by Human Finger
[0046] In general, as described above, the light that enters the finger will be attenuated by skin, fat, muscle, blood, and bone. For example, it has been observed that absorption and scattering of light by the human finger can reduce the power of transmitted light within the NIR region of 850 nm to 1100 nm by a factor of approximately 200. As a result, the total IR power transmitted through the finger is approximately only 25 microwatts (μW) (e.g., 5mW/200) in the entire wavelength region covered by the four IREDs, typically 850 nm to 1 100 nm.
Small Collection Solid Angle by Coupling Optics
[0047] Light is emitted from the exit aperture 306 in all directions in the
2π solid angle beneath the finger. In conventional optical designs it is difficult to collect most light power transmitted through the finger because the exit
SLW Docket No. 2743.003WOI 9 aperture 306 cannot be treated as a point source. Typically, the total light power collected using optical layout shown in Fig. 3 is only about 10%, or a power reduction by a factor of 10 to 2.5 μW within the entire wavelength region covered by the four IREDs, typically 850 nm to 1100 nm. Note that this is the optical power sent to all detectors in FIG. 3.
Number of Detectors
[0048] Moreover, optical systems such as shown in FIG. 3, may require as many as twenty (20) to thirty (30) diode detectors to obtain accurate information regarding chemical components in blood. Therefore, the light power goes to each detector will be about 125 nW or less.
Narrow Band-Pass Filter
[0049] The interference filter placed on top of each detector typically has a full width at half maximum (FWHM) bandwidth of 10 nm, which reduces the light power by a factor of 25 to 5 nW, assuming a uniform power distribution across the entire wavelength region from 850 nm to 1100 nm. Furthermore, the peak transmittance of each interference filter is about 50% or less. Accordingly, the light power received by each detector is reduced to about 2.5 nW or less.
Photoelectric Conversion Efficiency
[0050] The photoelectric conversion efficiency for Silicon Diode detectors ranges from 0.1 amps/watts (AAV) at 1100 nm to about 0.5 AAV at 900 nm. As a result, depending on the center wavelength of the corresponding interference filter, the photocurrent produced by each detector is between 0.25 nano-amps or less (nA) to 1.25 nA or less for each detector. The corresponding high end shot noise, within 10 Hz bandwidth, is about 2.0 x 10"4 Absorbance (p- p) or larger, which is over a factor of 6 of what is required for accurate determination of the value of ΔA, as defined by equation (5), with an S/N ratio of 100. In other word, to reach the desirable S/N ratio of 100: 1 for ΔA, light power received by the detectors should be increased over 40 folds. [0051] FIG. 4 A illustrates an optical configuration for performing optical detection of a biological sample according to one aspect of the present optical measurement system 400. A light source 402 generates a plurality of
SLW Docket No. 2743.003WO1 10 light beams 404, 406, 408, 410. The light source 402 may be incandescent light sources or infrared emitting diodes, for example. According to one aspect of the optical measurement system 400, each of the light beams 404, 406, 408, 410 have a different wavelength or a different wavelength range. For example, the first light beam 404 may have a wavelength range between 850 - 920 nm, the second light beam 406 may have a wavelength range between 900 - 980 nm, the third light beam 408 may have a wavelength between 970 - 1050 nm, and the fourth light beam 410 may have a wavelength between 1030-1100 nm. The total wavelength range may include from about 800 nm to about 1600nm, for example. Although the optical measurement system 400 is described herein as generating four (4) light beams, it is contemplated that the light source can be altered to generate fewer light beams or additional light beams in other embodiments. [0052] The light beams 404, 406, 408, 410 from the light source 402 enter a light illumination funnel 412 through an entrance opening 414 and exit the light illumination funnel 412 through an exit opening 416. The diameter of the exit opening 416 of the light illumination funnel 412 is smaller than or equal to the diameter of the entrance opening 414. For example, according to one embodiment the diameter of the entrance opening 414 is approximately 0.625 (5/8) inches and the diameter of the exit opening 416 is approximately 0.25 (1/4) inches. Accordingly, in contrast to the configuration depicted in FIG. 3, the light illumination funnel 412 focuses the light beams 404, 406, 408, 410 in the same general direction toward the top of the finger of a user. The light illumination funnel may significantly increase the total light power received by the target area in comparison to the configuration of FIG. 3, and therefore substantially increase the Signal-to-Noise Ratio.
[0053] FIG. 5 depicts a cross sectional view of the light illumination component or funnel 412. According to one aspect, the light illumination funnel 412 has a substantially cylindrical outer wall 502 with diameter Dl, and a central cavity defined by an inner wall 506 that is of a frusto-conical shape and two light entrance/exit openings 508 and 504. The opening 508 (second opening) has a smaller diameter, D3, and opening 504 (first opening) has a larger diameter, D2. The separation distance between the two light openings is L, and the Half Angle of the frusto-conical shape of the inner surface is α. According to one
SLW Docket No. 2743.Q03WO1 1 1 embodiment of the invention the value of Half Angle α ranges from 10 to 15 degrees. The Half Angles may be less than about 25 degrees, for example. The light illumination funnel 412 may be formed from plastic, metal or other suitable material or compound/layers of material, with any desired refractive index(es). According to one aspect, the light illumination funnel 412 is formed from metal and the surface of inner wall 506 is made highly reflective. When configured properly, the light intensity at the exit 508 may be increased by a factor of 50 to 100 over the light intensity at the entrance 504. [0054] FIG. 6 depicts components of the light source 402 according to one aspect of the optical measurement system 400. A circuit board may be positioned near or in contact with the first opening of the funnel and may include light sources mounted on or in contact with the board. In one example, a plurality of IREDs 602, 604, 606, and 608 are mounted to a printed circuit board (PCB) 610. The PCB 610 receives electric power through a power line 612 that is connected to a power source (e.g., power source 201) such as a battery. When the electric power is supplied through the power line 612, each of the IREDs 602, 604, 606, and 608 receives power and generates a plurality of light beams (e.g., light beams 404, 406, 408, 410). Notably, IREDs with similar operational current can be connected in series to increase battery life. The light source may be mounted within the funnel or above the funnel, such as by being surrounded by a housing, for example.
[0055] According to one aspect, the light illumination funnel 412 may be mounted to the PCB 610 via screws, posts or other connecting means. The frusto-conical shape of the inner surface of the light illumination funnel 412 serves to concentrate and focus the light beams 404, 406, 408, 410 from the IREDs 602, 604, 606, 608 into a generally conical beam toward the finger. [0056] FIG. 7 depicts cross-section view of another embodiment of the light illumination funnel 412 with a three-dimensional (3-D) IRED array matrix 702 disposed therein. Multiple light sources, such as IREDs, may be positioned in three-dimensional layers and arranged to optimize light intensity. The light sources may be positioned in horizontal and vertical layers, for example. According to this embodiment, there are a total of twenty six (26) IREDs included in the 3-D array matrix. The IREDs are arranged in four (4) layers. A first row, as indicated by 704, includes four (4) IREDs (two IREDs not shown),
S LW Docket No. 2743.003 WO I 12 a second layer, as indicated by 706, includes five (5) IREDs (two IREDs not shown), a third layer, as indicated by 708, includes seven (7) IREDs (four IREDs not shown), and a fourth layer, as indicated by 710, includes ten (10) IREDs (six IREDs not shown). Power line 712 provides power for all IREDs. According to other embodiments, other IRED patterns may also be utilized. Any number of light sources or layers may be utilized to optimize the light intensity. [0057] Because IREDs are optically transparent to infrared lights, the light loss due to blocking effect within the funnel cavity should be low and the structure shown in FIG. 7 is expect to collect over 85% light power emitted from the IREDs 3-D array in the light funnel cavity. As a result, the total light power transmitted through the 0.25-inch diameter of the exit opening 416 of the light illumination funnel 412 should be approximately 55 mW (e.g., 26 x 2.5 mW x 0.85). Therefore, the total light power transmitted through the 0.25 inch opening above the finger in present optical measurement system 400 is approximately eleven (11) times of the corresponding power reached at the aperture 306 (e.g., 5mW) of the configuration described in reference to FIG. 3. Moreover, the increased light power received at the finger will increase the amount of light power that can be transmitted through the finger and, thus, increases the light power that can be detected at the detector block 428. [0058] Referring back to FIG. 4 A, light beams 404, 406, 408, 410 are attenuated by the finger and components of the optical measurement system 400. The attenuated light beams then pass an exit aperture 418, collected by an aspheric lens 430. The beams 432 exiting the lens 430 may then pass through filters 426 to detectors 428. [0059] The major advantage of using an aspheric lens 430 for light collection is its much larger solid angle for light collection. When configured properly, the total light power received by each detector may be increased by a factor 3 to 4 when an aspheric lens 430 is used for collecting light emitted from the target area in comparison to the light collection configuration shown in FIG. 3. The combination of utilizing a light illumination funnel 412 and an aspheric lens 430 as light collector may increase the light power received by each detector by about 20 to about 40 times in comparison to the optical configuration shown in FIG. 3
SLW Docket No. 2743.003WOI 1 3 [0060] The detector block 428 is positioned beneath the aspheric lens
430 and may include a plurality of light-sensing devices, such as an array of photodiodes. According to one aspect of the optical measurement system 400, each of the light-sensing devices detects a specific wavelength of light as defined by a corresponding interference filter 426 placed on top of the detector.
[0061] A processor (e.g., processor 243) can be coupled to the detector block 428 and configured to calculate a change of current signals generated by the light sensing devices. For example, as described above in reference to FIG. 2, the processor 243 executes an algorithm such as shown in equation (5) to calculate the change in the light absorption (ΔA) solely caused by the blood in the finger. Thereafter, this quantitative calculation of light absorption of the blood can be used to determine a characteristic of the blood. [0062] FIG. 4B illustrates another optical configuration for performing optical detection of a biological sample according to one aspect of the present optical measurement system 400. A light source 402 generates a plurality of light beams 404, 406, 408, 410. The light source 402 may be incandescent light sources or infrared emitting diodes, for example. According to one aspect of the optical measurement system 400, each of the light beams 404, 406, 408, 410 have a different wavelength or a different wavelength range. For example, the first light beam 404 may have a wavelength range between 850 - 920 nm, the second light beam 406 may have a wavelength range between 900 - 980 nm, the third light beam 408 may have a wavelength between 970 - 1050 nm, and the fourth light beam 410 may have a wavelength between 1030-1100 nm. The total wavelength range may include from about 800 nm to about 1200nm, for example. Although the optical measurement system 400 is described herein as generating four (4) light beams, it is contemplated that the light source can be altered to generate fewer light beams or additional light beams in other embodiments. [0063] The light beams 404, 406, 408, 410 from the light source 402 enter a light illumination funnel 412 through an entrance opening 414 and exit the light illumination funnel 412 through an exit opening 416. The diameter of the exit opening 416 of the light illumination funnel 412 is smaller than or equal to the diameter of the entrance opening 414. For example, according to one embodiment the diameter of the entrance opening 414 is approximately 0.625
SLW Docket No. 2743.003WO1 14 (5/8) inches and the diameter of the exit opening 416 is approximately 0.25 (1/4) inches. Accordingly, in contrast to the configuration depicted in FIG. 3, the light illumination funnel 412 focuses the light beams 404, 406, 408, 410 in the same general direction toward the top of the finger of a user. The light illumination funnel may significantly increase the total light power received by the target area in comparison to the configuration of FIG. 3, and therefore substantially increase the Signal-to-Noise Ratio.
[0064] As shown by FIG. 4B, light beams 404, 406, 408, 410 are attenuated by the finger and components of the optical measurement system 400. The attenuated light NIR beams then pass an exit aperture 418, collected by a condenser lens 420, and projected onto a transmission grating device 422. [0065] As shown in FIG. 4B, the transmission diffraction grating 422 angularly resolves the various wavelength components of the mixed NIR light beams into a spectrum with wavelength increasing monotonically in the direction depicted by the arrow. In other words, because the diffraction angle of a particular light beam depends on the wavelength of the light beam, each of the light beams can be separated by wavelength. The optical spectrum 424 comes out from the transmission diffraction grating 422 is then narrowed down by interference filter array 426 and detected by diode array 428. The center wavelength of each interference filter in the filter array 426 is arranged to increase monotonically to coincide with corresponding wavelength component of the spectrum come from the transmission diffraction grating 422. [0066] In comparison to the collection optical structure in FIG. 3 where entire light power distribution from 850 nm to 1100 nm is sent to every detector, the approach utilizing transmission diffraction grating will send each detector only the wavelength components near the center wavelength of the corresponding filter. As a result, the amount of light wasted is dramatically reduced, and the light power received by the photodiodes is increased by a factor of 10 to 20 over the light collection configuration describe in reference to FIG. 3. Therefore, the combination of utilizing a light illumination funnel 412, an aspheric lens 420 as light collector, and a transmission grating 422 as wavelength separation device may increase the light power received by the photodiodes by about 100 to about 200 times in comparison to the optical configuration shown in FIG. 3
SLW Docket No. 2743.003WOI 1 5 [0067] Embodiments of the invention may also include methods of using the apparatus as describe above or a light collection system, A light source may contact a target through an illumination funnel, sufficient to generate transmitted, transflected or reflected light. The transmitted, transflected or reflected light may enter a light collection system and be directed to one or more detectors, for example.
SLW Docket No. 2743.003WOI 1 6

Claims

CLAIMS What is claimed is:
1. An apparatus, comprising: a light source to generate a plurality of light beams, each of the plurality of light beams having a different wavelength range; a light funnel to direct the plurality of light beams to the target area; an aperture to direct the plurality of light beams emitting from the target area to a lens, the lens configured to collect the light beams emitting from the target area; a detector comprising a plurality of light-sensing devices each configured to detect a light beam and configured to generate an output signal indicative of an intensity of light detected; and a processor for determining the blood characteristic as a function of each generated output signal
2. The apparatus of claim 1, further comprising a plurality of interference filters each configured to pass a different one of the plurality of light beams emitting from the target area as a function of wavelength range.
3. The apparatus of any one of claims 1-2, further comprising a transmission grating, positioned between the lens and detector.
4. The apparatus of any one of claims 1-3, wherein the light source comprises one or more light emitting diodes.
5. The apparatus of any one of claims 1 -4, wherein the light source comprises one or more incandescent light sources.
SLW Docket No. 2743.003WOI 1 7
6. The apparatus of any one of claims 1 -5, wherein the wavelength range comprises differing wavelength ranges between about 800 nm and about 1600 inn.
7. The apparatus of any one of claims 1-6, wherein the light source is positioned at the entrance opening of the light illumination funnel.
8. A light collection system, comprising: a lens, positioned adjacent a target area; an aperture, positioned between the lens and target area and configured to direct a plurality of light beams emitting from the target area; and one or more filters.
9. The light collection system of claim 8, further comprising a transmission grating, positioned between the lens and one or more filters.
10. The light collection system of any one of claims 8-9, wherein the one or more filters are interference filters.
11. The light collection system of any one of claims 8-10, wherein the interference filters are each configured to pass a different one of the plurality of light beams emitting from the target area as a function of wavelength range.
12. The light collection system of any one of claims 8-11, further comprising one or more detectors positioned near or in contact with the one or more filters.
13. The light collection system of any one of claims 8-12, wherein the one or more detectors comprises a detector array.
14. The light collection system of any one of claims 8-13, wherein the plurality of light beams is generated from incandescent light sources.
SLW Docket No. 2743.003WOI 1 8
15. The light collection system of any one of claims 8-14, wherein the plurality of light beams is generated from or infrared emitting diodes.
SLW Docket No. 2743.003WO1 19
PCT/US2008/011438 2007-10-04 2008-10-03 Optical device components WO2009045492A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
RU2010117396/28A RU2478197C2 (en) 2007-10-04 2008-10-03 Apparatus for non-invasive determination of chemical components of blood (versions)
AU2008307505A AU2008307505B2 (en) 2007-10-04 2008-10-03 Optical device components
BRPI0818177-2A BRPI0818177B1 (en) 2007-10-04 2008-10-03 DEVICE
JP2010527994A JP2010540964A (en) 2007-10-04 2008-10-03 Optical device components
CA2700996A CA2700996C (en) 2007-10-04 2008-10-03 Optical device components
CN2008801167527A CN101903757B (en) 2007-10-04 2008-10-03 Optical device components
EP08836010.2A EP2198268B1 (en) 2007-10-04 2008-10-03 Optical apparatus for determining a blood characteristic
HK11105392.0A HK1151351A1 (en) 2007-10-04 2011-05-31 Optical device components

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97746707P 2007-10-04 2007-10-04
US60/977,467 2007-10-04

Publications (1)

Publication Number Publication Date
WO2009045492A1 true WO2009045492A1 (en) 2009-04-09

Family

ID=40526567

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/011438 WO2009045492A1 (en) 2007-10-04 2008-10-03 Optical device components

Country Status (10)

Country Link
US (1) US7809418B2 (en)
EP (1) EP2198268B1 (en)
JP (1) JP2010540964A (en)
CN (1) CN101903757B (en)
AU (1) AU2008307505B2 (en)
BR (1) BRPI0818177B1 (en)
CA (1) CA2700996C (en)
HK (1) HK1151351A1 (en)
RU (1) RU2478197C2 (en)
WO (1) WO2009045492A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7809418B2 (en) 2007-10-04 2010-10-05 The Curators Of The University Of Missouri Optical device components
WO2010114736A1 (en) 2009-04-01 2010-10-07 The Curators Of The University Of Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
CN102083360A (en) * 2008-05-22 2011-06-01 密苏里大学董事会 Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US7961305B2 (en) 2007-10-23 2011-06-14 The Curators Of The University Of Missouri Optical device components
US10542919B2 (en) 2008-03-25 2020-01-28 St. Louis Medical Devices, Inc. Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008299938A1 (en) * 2007-09-13 2009-03-19 The Curators Of The University Of Missouri Optical device components
EP2326239B1 (en) 2008-07-03 2017-06-21 Masimo Laboratories, Inc. Protrusion for improving spectroscopic measurement of blood constituents
US20100030040A1 (en) 2008-08-04 2010-02-04 Masimo Laboratories, Inc. Multi-stream data collection system for noninvasive measurement of blood constituents
US8688183B2 (en) 2009-09-03 2014-04-01 Ceracor Laboratories, Inc. Emitter driver for noninvasive patient monitor
US8766191B2 (en) * 2009-10-06 2014-07-01 The Curators Of The University Of Missouri External/internal optical adapter for FTIR spectrophotometer
JP5695935B2 (en) * 2011-02-24 2015-04-08 横河電機株式会社 Infrared analyzer
US9170194B2 (en) * 2012-03-28 2015-10-27 Yokogawa Electric Corporation Material property measuring apparatus
US9795329B2 (en) * 2014-01-10 2017-10-24 Glucovista Inc. Non-invasive device and method for measuring a substance concentration
RU2576843C2 (en) * 2014-04-08 2016-03-10 Тахир Хусанович Холматов Glucose oxidase method for non-invasive blood sugar measurement, glucose oxidase method for calibration of agents for non-invasive blood sugar measurement
JP6690143B2 (en) * 2015-07-10 2020-04-28 日立化成ダイアグノスティックス・システムズ株式会社 Detector and analyzer
US10436773B2 (en) 2016-01-18 2019-10-08 Jana Care, Inc. Mobile device based multi-analyte testing analyzer for use in medical diagnostic monitoring and screening
FR3048173B1 (en) * 2016-02-29 2018-03-16 Commissariat A L'energie Atomique Et Aux Energies Alternatives METHOD FOR ESTIMATING CARDIAC FREQUENCY AND DEVICE THEREOF
CN106885806A (en) * 2016-03-04 2017-06-23 摩瑞尔电器(昆山)有限公司 A kind of big data system and method based on laser detection blood
CN109883978A (en) * 2019-03-26 2019-06-14 翼捷安全设备(昆山)有限公司 Multiple light courcess light cone array gas sensor and detection method
US11536732B2 (en) 2020-03-13 2022-12-27 Jana Care, Inc. Devices, systems, and methods for measuring biomarkers in biological fluids
CN113925456B (en) * 2020-07-14 2023-01-24 先阳科技有限公司 Positioning method, positioning device, electronic equipment and storage medium
NL2026905B1 (en) 2020-11-16 2022-06-30 Pharmamatch B V Pharmaceutical granulate formulation and method for the preparation thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997769A (en) * 1985-06-21 1991-03-05 Radiometer A/S Method and an apparatus for determining blood components
US5086229A (en) 1989-01-19 1992-02-04 Futrex, Inc. Non-invasive measurement of blood glucose
WO1995005599A1 (en) 1993-08-16 1995-02-23 Eli Lilly And Company Non-invasive near-infrared quantitative measurement instrument
EP0781527A1 (en) 1995-11-29 1997-07-02 Instrumentarium Oy Pulsoximeter sensor
US6167290A (en) 1999-02-03 2000-12-26 Bayspec, Inc. Method and apparatus of non-invasive measurement of human/animal blood glucose and other metabolites
US6205354B1 (en) * 1999-06-18 2001-03-20 University Of Utah Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue
US20060152726A1 (en) * 2005-01-13 2006-07-13 The Curators Of The University Of Missouri Ultrasensitive spectrophotometer

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441343A (en) 1944-07-07 1948-05-11 Borg Warner Photoelectric ring gauge
US3621268A (en) 1967-12-19 1971-11-16 Int Standard Electric Corp Reflection type contactless touch switch having housing with light entrance and exit apertures opposite and facing
US3954560A (en) 1970-05-06 1976-05-04 Commissariat A L'energie Atomique Nuclear fuel assembly
US3910701A (en) 1973-07-30 1975-10-07 George R Henderson Method and apparatus for measuring light reflectance absorption and or transmission
FR2252584B3 (en) 1973-11-23 1976-10-08 Ulmic Sa
US4014321A (en) 1974-11-25 1977-03-29 March Wayne F Non-invasive glucose sensor system
SU1193541A1 (en) * 1981-01-14 1985-11-23 Краснодарское Отделение Всесоюзного Ордена Трудового Красного Знамени Научно-Исследовательского Института Источников Тока Photometer
US4632559A (en) 1982-11-29 1986-12-30 Miles Laboratories, Inc. Optical readhead
US4655225A (en) 1985-04-18 1987-04-07 Kurabo Industries Ltd. Spectrophotometric method and apparatus for the non-invasive
US4781195A (en) 1987-12-02 1988-11-01 The Boc Group, Inc. Blood monitoring apparatus and methods with amplifier input dark current correction
DE3818229C1 (en) 1988-05-28 1989-12-07 Messerschmitt-Boelkow-Blohm Gmbh, 8012 Ottobrunn, De
US5009230A (en) 1988-05-31 1991-04-23 Eol, Inc. Personal glucose monitor
US5028787A (en) 1989-01-19 1991-07-02 Futrex, Inc. Non-invasive measurement of blood glucose
US5077476A (en) 1990-06-27 1991-12-31 Futrex, Inc. Instrument for non-invasive measurement of blood glucose
US5204532A (en) 1989-01-19 1993-04-20 Futrex, Inc. Method for providing general calibration for near infrared instruments for measurement of blood glucose
US5112124A (en) 1990-04-19 1992-05-12 Worcester Polytechnic Institute Method and apparatus for measuring the concentration of absorbing substances
US5137023A (en) 1990-04-19 1992-08-11 Worcester Polytechnic Institute Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography
US5183042A (en) 1989-05-23 1993-02-02 Vivascan Corporation Electromagnetic method and apparatus to measure constituents of human or animal tissue
US5222496A (en) 1990-02-02 1993-06-29 Angiomedics Ii, Inc. Infrared glucose sensor
US6181958B1 (en) 1998-02-05 2001-01-30 In-Line Diagnostics Corporation Method and apparatus for non-invasive blood constituent monitoring
US5255171A (en) 1991-11-27 1993-10-19 Clark L Douglas Colored light source providing intensification of initial source illumination
WO1994013199A1 (en) 1992-12-10 1994-06-23 Sunshine Medical Instruments, Inc. Non-invasive blood glucose measurement
US5398681A (en) 1992-12-10 1995-03-21 Sunshine Medical Instruments, Inc. Pocket-type instrument for non-invasive measurement of blood glucose concentration
DE4243142A1 (en) 1992-12-19 1994-06-23 Boehringer Mannheim Gmbh Device for in-vivo determination of an optical property of the aqueous humor of the eye
US5313941A (en) 1993-01-28 1994-05-24 Braig James R Noninvasive pulsed infrared spectrophotometer
US5515847A (en) 1993-01-28 1996-05-14 Optiscan, Inc. Self-emission noninvasive infrared spectrophotometer
US5615672A (en) 1993-01-28 1997-04-01 Optiscan, Inc. Self-emission noninvasive infrared spectrophotometer with body temperature compensation
US5423983A (en) 1994-02-07 1995-06-13 Chiang; Jean Oil filter with a magnetic unit
US5553613A (en) 1994-08-17 1996-09-10 Pfizer Inc. Non invasive blood analyte sensor
US5615673A (en) * 1995-03-27 1997-04-01 Massachusetts Institute Of Technology Apparatus and methods of raman spectroscopy for analysis of blood gases and analytes
JPH08320287A (en) * 1995-05-24 1996-12-03 Satake Eng Co Ltd Spectral analyzing and measuring device
US6517283B2 (en) 2001-01-16 2003-02-11 Donald Edward Coffey Cascading chute drainage system
AU6256196A (en) 1995-06-07 1996-12-30 Blackbox, Inc. Method for noninvasive intermittent and/or continuous hemogl obin, arterial oxygen content, and hematocrit determination
US6025597A (en) 1995-10-17 2000-02-15 Optiscan Biomedical Corporation Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body
JP3228098B2 (en) * 1995-11-01 2001-11-12 横河電機株式会社 Light source
US5703364A (en) 1996-02-15 1997-12-30 Futrex, Inc. Method and apparatus for near-infrared quantitative analysis
US5666956A (en) 1996-05-20 1997-09-16 Buchert; Janusz Michal Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation
DE69737031T2 (en) 1996-07-19 2007-04-26 Daedalus I, Llc DEVICE FOR NON-INVASIVE DETERMINATION OF BLOOD PARAMETERS
US6120460A (en) 1996-09-04 2000-09-19 Abreu; Marcio Marc Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
US5910109A (en) 1997-02-20 1999-06-08 Emerging Technology Systems, Llc Non-invasive glucose measuring device and method for measuring blood glucose
GB9704737D0 (en) 1997-03-07 1997-04-23 Optel Instr Limited Biological measurement system
US7890158B2 (en) 2001-06-05 2011-02-15 Lumidigm, Inc. Apparatus and method of biometric determination using specialized optical spectroscopy systems
JPH1137931A (en) * 1997-07-14 1999-02-12 Tokimec Inc Absorptiometer
US6043492A (en) 1997-10-27 2000-03-28 Industrial Technology Research Institute Non-invasive blood glucose meter
US6006119A (en) 1998-02-04 1999-12-21 Polestar Technologies, Inc. Non-invasive optical measurement of blood hematocrit
US6721582B2 (en) 1999-04-06 2004-04-13 Argose, Inc. Non-invasive tissue glucose level monitoring
US6097975A (en) 1998-05-13 2000-08-01 Biosensor, Inc. Apparatus and method for noninvasive glucose measurement
AU742552B2 (en) 1998-06-24 2002-01-03 Transderm Technologies Llc Non-invasive transdermal detection of analytes
WO2000001294A1 (en) 1998-07-04 2000-01-13 Whitland Research Limited Non-invasive measurement of blood analytes
US6208788B1 (en) 1998-07-29 2001-03-27 Ultradent Products, Inc. Apparatus and methods for concentrating light through fiber optic funnels coupled to dental light guides
US6064898A (en) 1998-09-21 2000-05-16 Essential Medical Devices Non-invasive blood component analyzer
US6424851B1 (en) 1998-10-13 2002-07-23 Medoptix, Inc. Infrared ATR glucose measurement system (II)
US6134458A (en) 1998-12-15 2000-10-17 Futrex Inc. Light probe for a near-infrared body chemistry measurement instrument
US6067463A (en) * 1999-01-05 2000-05-23 Abbott Laboratories Method and apparatus for non-invasively measuring the amount of glucose in blood
US6151517A (en) 1999-01-22 2000-11-21 Futrex Inc. Method and apparatus for noninvasive quantitative measurement of blood analytes
IL129790A0 (en) 1999-03-09 2000-02-29 Orsense Ltd A device for enhancement of blood-related signals
US6337564B2 (en) 1999-04-13 2002-01-08 Alcoa Inc. Detecting and classifying hard and soft inclusions in liquid metal
US20020010563A1 (en) 1999-06-15 2002-01-24 S. Michael Ratteree Method for achieving and verifying increased productivity in an industrial process
CA2382197A1 (en) 1999-08-19 2001-02-22 Washington State University Research Foundation Methods for determining the physiological state of a plant
WO2001016578A1 (en) * 1999-08-31 2001-03-08 Cme Telemetrix Inc. Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths
EP1251772B1 (en) 1999-12-22 2012-11-14 Orsense Ltd. A method of optical measurements for determining various parameters of the patient's blood
CN1198536C (en) 1999-12-28 2005-04-27 平迪产品公司 Method and apparatus for non-invasive analysis of blood glucose
US7806831B2 (en) 2000-03-02 2010-10-05 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
GB0013964D0 (en) 2000-06-09 2000-08-02 Whitland Res Ltd Monitor
IL136673A0 (en) 2000-06-11 2001-06-14 Orsense Ltd A method and device for measuring the concentration of glucose or other substance in blood
US6522903B1 (en) 2000-10-19 2003-02-18 Medoptix, Inc. Glucose measurement utilizing non-invasive assessment methods
US6865408B1 (en) 2001-04-11 2005-03-08 Inlight Solutions, Inc. System for non-invasive measurement of glucose in humans
US6574490B2 (en) 2001-04-11 2003-06-03 Rio Grande Medical Technologies, Inc. System for non-invasive measurement of glucose in humans
US20020161289A1 (en) 2001-04-30 2002-10-31 Hopkins George W. Detector array for optical spectrographs
DE10123633A1 (en) 2001-05-09 2003-02-06 Ego Elektro Geraetebau Gmbh sensor element
WO2003010510A2 (en) 2001-07-25 2003-02-06 Argose, Inc. Adjunct quantitative system and method for non-invasive measurement of in vivo analytes
US20050010091A1 (en) * 2003-06-10 2005-01-13 Woods Joe W. Non-invasive measurement of blood glucose using retinal imaging
JP2003215033A (en) * 2002-01-18 2003-07-30 Matsushita Electric Works Ltd Device and method for quantitatively determining living components
RU2234242C2 (en) * 2002-03-19 2004-08-20 Федеральное государственное унитарное предприятие Научно-исследовательский институт "Полюс" Method for determining biological tissue condition
CN1327812C (en) 2002-03-25 2007-07-25 Tyt技研株式会社 Noninvasive blood component value measuring instrument and method
US6684099B2 (en) * 2002-04-04 2004-01-27 Inlight Solutions, Inc. Apparatus and method for reducing spectral complexity in optical sampling
US7133711B2 (en) 2002-08-07 2006-11-07 Orsense, Ltd. Method and system for decomposition of multiple channel signals
US7233817B2 (en) 2002-11-01 2007-06-19 Brian Yen Apparatus and method for pattern delivery of radiation and biological characteristic analysis
US20040106163A1 (en) 2002-11-12 2004-06-03 Workman Jerome James Non-invasive measurement of analytes
US6968221B2 (en) 2003-03-14 2005-11-22 Futrex, Inc. Low-cost method and apparatus for non-invasively measuring blood glucose levels
KR100464324B1 (en) 2003-03-17 2005-01-03 삼성전자주식회사 Method and apparatus for measuring concentration of constituents in body fluids
JP2004290544A (en) * 2003-03-28 2004-10-21 Citizen Watch Co Ltd Blood analyzer
US6958039B2 (en) 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US7266400B2 (en) 2003-05-06 2007-09-04 Orsense Ltd. Glucose level control method and system
US20040225206A1 (en) 2003-05-09 2004-11-11 Kouchnir Mikhail A. Non-invasive analyte measurement device having increased signal to noise ratios
EP2465420A3 (en) * 2003-06-03 2012-10-24 Orsense Ltd. Method and system for use in non-invasive optical measurements of blood parameters
US6993372B2 (en) 2003-06-03 2006-01-31 Orsense Ltd. Method and system for use in non-invasive optical measurements of blood parameters
US20060224057A1 (en) 2003-10-21 2006-10-05 Oculir, Inc. Methods for non-invasive analyte measurement
US7020506B2 (en) 2003-11-06 2006-03-28 Orsense Ltd. Method and system for non-invasive determination of blood-related parameters
JP3590053B1 (en) * 2004-02-24 2004-11-17 株式会社日立製作所 Blood glucose measurement device
US20060258918A1 (en) 2004-04-14 2006-11-16 Oculir, Inc. Combination Analyte Measurement Device and Method of Use
US7313425B2 (en) 2004-07-08 2007-12-25 Orsense Ltd. Device and method for non-invasive optical measurements
JP5324095B2 (en) 2004-08-24 2013-10-23 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for imaging blood vessel segments
JP2006071589A (en) * 2004-09-06 2006-03-16 Univ Kansai Color measuring instrument and light source device
EP1855586A2 (en) 2005-02-09 2007-11-21 Inlight Solutions, Inc. Methods and apparatuses for noninvasive determinations of analytes
US7616368B2 (en) 2005-02-23 2009-11-10 Pixtronix, Inc. Light concentrating reflective display methods and apparatus
ATE468808T1 (en) 2005-03-01 2010-06-15 Masimo Laboratories Inc NON-INVASIVE MULTIPARAMETER PATIENT MONITOR
EP1874178A4 (en) 2005-04-13 2009-12-09 Glucolight Corp Method for data reduction and calibration of an oct-based blood glucose monitor
US7409239B2 (en) 2005-05-05 2008-08-05 The Hong Kong Polytechnic University Method for predicting the blood glucose level of a person
US7254432B2 (en) 2005-08-17 2007-08-07 Orsense Ltd. Method and device for non-invasive measurements of blood parameters
WO2007122557A2 (en) 2006-04-21 2007-11-01 Philips Intellectual Property & Standards Gmbh Non-invasive glucose sensor
EP2073694A4 (en) 2006-09-27 2010-12-08 Woolsthorpe Technologies Llc Pulse amplitude indexing method and apparatus
US20080144004A1 (en) 2006-12-15 2008-06-19 Futrex Inc. Optical Spectrophotometer
US8029164B2 (en) 2007-05-21 2011-10-04 Goldeneye, Inc. LED light recycling cavity with integrated optics
AU2008299938A1 (en) 2007-09-13 2009-03-19 The Curators Of The University Of Missouri Optical device components
US7809418B2 (en) 2007-10-04 2010-10-05 The Curators Of The University Of Missouri Optical device components
US7961305B2 (en) 2007-10-23 2011-06-14 The Curators Of The University Of Missouri Optical device components
US20090196025A1 (en) 2008-02-01 2009-08-06 Disney Enterprises, Inc. Cone assembly for illuminating cotton candy with multi-colored, diffused light
US20100030040A1 (en) 2008-08-04 2010-02-04 Masimo Laboratories, Inc. Multi-stream data collection system for noninvasive measurement of blood constituents

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997769A (en) * 1985-06-21 1991-03-05 Radiometer A/S Method and an apparatus for determining blood components
US5086229A (en) 1989-01-19 1992-02-04 Futrex, Inc. Non-invasive measurement of blood glucose
WO1995005599A1 (en) 1993-08-16 1995-02-23 Eli Lilly And Company Non-invasive near-infrared quantitative measurement instrument
EP0781527A1 (en) 1995-11-29 1997-07-02 Instrumentarium Oy Pulsoximeter sensor
US6167290A (en) 1999-02-03 2000-12-26 Bayspec, Inc. Method and apparatus of non-invasive measurement of human/animal blood glucose and other metabolites
US6205354B1 (en) * 1999-06-18 2001-03-20 University Of Utah Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue
US20060152726A1 (en) * 2005-01-13 2006-07-13 The Curators Of The University Of Missouri Ultrasensitive spectrophotometer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2198268A4

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7809418B2 (en) 2007-10-04 2010-10-05 The Curators Of The University Of Missouri Optical device components
US7961305B2 (en) 2007-10-23 2011-06-14 The Curators Of The University Of Missouri Optical device components
US11147482B2 (en) 2008-03-25 2021-10-19 St. Louis Medical Devices, Inc. Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose
US10542919B2 (en) 2008-03-25 2020-01-28 St. Louis Medical Devices, Inc. Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose
US9629576B2 (en) 2008-05-22 2017-04-25 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US9814415B2 (en) 2008-05-22 2017-11-14 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US11553859B2 (en) 2008-05-22 2023-01-17 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US11076781B2 (en) 2008-05-22 2021-08-03 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US9566024B2 (en) 2008-05-22 2017-02-14 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US9579049B2 (en) 2008-05-22 2017-02-28 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US10973442B2 (en) 2008-05-22 2021-04-13 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
EP2299900B1 (en) * 2008-05-22 2017-06-07 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US9788764B2 (en) 2008-05-22 2017-10-17 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US8340738B2 (en) 2008-05-22 2012-12-25 The Curators Of The University Of Missouri Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US9877670B2 (en) 2008-05-22 2018-01-30 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US10070809B2 (en) 2008-05-22 2018-09-11 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US10080515B2 (en) 2008-05-22 2018-09-25 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
CN102083360A (en) * 2008-05-22 2011-06-01 密苏里大学董事会 Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
US10959650B2 (en) 2008-05-22 2021-03-30 St. Louis Medical Devices, Inc. Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis
EP2413784A1 (en) * 2009-04-01 2012-02-08 The Curators Of The University Of Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
EP2413784A4 (en) * 2009-04-01 2014-01-22 Univ Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
WO2010114736A1 (en) 2009-04-01 2010-10-07 The Curators Of The University Of Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
US8552359B2 (en) 2009-04-01 2013-10-08 The Curators of the Univesity of Missouri Optical spectroscopy device for non-invasive blood glucose detection and associated method of use

Also Published As

Publication number Publication date
EP2198268B1 (en) 2022-03-16
HK1151351A1 (en) 2012-01-27
CA2700996C (en) 2016-12-13
CN101903757B (en) 2012-08-29
CN101903757A (en) 2010-12-01
BRPI0818177B1 (en) 2022-09-27
EP2198268A1 (en) 2010-06-23
JP2010540964A (en) 2010-12-24
AU2008307505A1 (en) 2009-04-09
AU2008307505B2 (en) 2013-01-31
RU2478197C2 (en) 2013-03-27
RU2010117396A (en) 2011-11-10
BRPI0818177A2 (en) 2022-01-18
CA2700996A1 (en) 2009-04-09
EP2198268A4 (en) 2016-04-06
US7809418B2 (en) 2010-10-05
US20090105565A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
AU2008307505B2 (en) Optical device components
US7961305B2 (en) Optical device components
CA2789658C (en) Optical spectroscopy device for non-invasive blood glucose detection and associated method of use
CA2699626C (en) Optical device components
US11147482B2 (en) Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose
US20210353186A1 (en) Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880116752.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08836010

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2700996

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008307505

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010527994

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008836010

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1311/KOLNP/2010

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2008307505

Country of ref document: AU

Date of ref document: 20081003

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010117396

Country of ref document: RU

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0818177

Country of ref document: BR

Free format text: PEDIDO RETIRADO EM RELACAO AO BRASIL, TENDO EM VISTA A NAO ACEITACAO DA ENTRADA NA FASE NACIONAL FACE A INTEMPESTIVIDADE, POIS O PRAZO PARA A REFERIDA ENTRADA EXPIRAVA EM 05/04/2010 (DIA UTIL POSTERIOR AO PRAZO DE 30 MESES CONTADOS DA DATA DE PRIORIDADE) E A ENTRADA SO OCORREU EM 06/04/2010, CONSIDERANDO QUE A PETICAO POR VIA POSTAL FOI ENVIADA AS 21:46H DO DIA 05/04/2010, CONFORME DOCUMENTO ENVIDADO NA PETICAO 020100077679, APOS O HORARIO DE ENCERRAMENTO DAS ATIVIDADES, E DE ACORDO COM O ITEM 4.2.1 DO ATO NORMATIVO 127/97 E ART 17 1O DA RESOLUCAO 77/2013 ?PRESUMIR-SE-A QUE OS PEDIDOS APRESENTADOS POR VIA POSTAL TERAO SIDO RECEBIDOS NA DATA DE POSTAGEM OU NO DIA UTIL IMEDIATAMENTE POSTERIO

ENP Entry into the national phase

Ref document number: PI0818177

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100406